Luckwel Pharmaceuticals Inc. Increase (Decrease) in Due to Officers and Stockholders
Luckwel Pharmaceuticals Inc. reported Increase (Decrease) in Due to Officers and Stockholders of $148.50 thousand for the 12-month period ending 2021-03-31, per its 10-K filed 2021-09-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDueToOfficersAndStockholders · last filed 2021-09-09
- Luckwel Pharmaceuticals Inc. increase (decrease) in due to officers and stockholders for the quarter ending 2021-03-31 was -$3.00K, a 103.53% decline year-over-year.
- Luckwel Pharmaceuticals Inc. increase (decrease) in due to officers and stockholders for the quarter ending 2020-12-31 was $54.00K, a 135.05% increase year-over-year.
- Luckwel Pharmaceuticals Inc. increase (decrease) in due to officers and stockholders for the quarter ending 2020-09-30 was $54.00K.
- Luckwel Pharmaceuticals Inc. increase (decrease) in due to officers and stockholders for the quarter ending 2020-06-30 was $43.50K.
- Luckwel Pharmaceuticals Inc. increase (decrease) in due to officers and stockholders for fiscal 2021 was $148.50K, a 3.13% increase from fiscal 2020.
- Luckwel Pharmaceuticals Inc. increase (decrease) in due to officers and stockholders for fiscal 2020 was $144.00K.
| Period end | Increase (Decrease) in Due to Officers and Stockholders 3 month | Increase (Decrease) in Due to Officers and Stockholders 6 month | Increase (Decrease) in Due to Officers and Stockholders 9 month | Increase (Decrease) in Due to Officers and Stockholders 12 month |
|---|---|---|---|---|
| 2021-03-31 | -$3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-09 | $51.00K derived: sum of 2 quarters · filed 2021-09-09 | $105.00K derived: sum of 3 quarters · filed 2021-09-09 | $148.50K 10-K · filed 2021-09-09 |
| 2020-12-31 | $54.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-09-08 | $108.00K derived: sum of 2 quarters · filed 2021-09-08 | $151.50K 10-Q · filed 2021-09-08 | $236.48K derived: sum of 4 quarters · filed 2021-09-09 |
| 2020-09-30 | $54.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-09-08 | $97.50K 10-Q · filed 2021-09-08 | $182.48K derived: sum of 3 quarters · filed 2021-09-09 | $205.45K derived: sum of 4 quarters · filed 2021-09-09 |
| 2020-06-30 | $43.50K 10-Q · filed 2021-09-07 | $128.48K derived: sum of 2 quarters · filed 2021-09-09 | $151.45K derived: sum of 3 quarters · filed 2021-09-09 | |
| 2020-03-31 | $84.98K derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-09 | $107.95K derived: sum of 2 quarters · filed 2021-09-09 | $144.00K 10-K · filed 2021-09-09 | |
| 2019-12-31 | $22.97K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-13 | $59.02K 10-Q · filed 2020-02-13 | ||
| 2019-09-30 | $36.05K 10-Q · filed 2019-11-14 | |||
| 2018-12-31 | $132.54K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-13 | $281.02K 10-Q · filed 2020-02-13 | ||
| 2018-09-30 | $148.48K 10-Q · filed 2019-11-14 | |||
| 2017-12-31 | $24.36K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-02-14 | $62.10K 10-Q · filed 2019-02-14 | ||
| 2017-09-30 | $37.74K 10-Q · filed 2018-11-14 |